tirzepatide off fda shortage list takes When the FDA declared the semaglutide shortage resolved in February 2025 and the tirzepatide shortage resolved in October 2024, https://www.daily-remedy.com/after-the-shortage FDA says this weight loss

10.1016/S0140-6736(17)31585-4 Lancet 16 Aviles-OlmosI.DicksonJ.KefalopoulouZ.DjamshidianA.EllP.SoderlundT.et al (2013)

Rather than follow the pricing of the pharma companies behind the products, some countries are able to provide licenses to generic companies to provide versions of the drugs that can be made available to the public at a lower price

Concentration range considerations Because tirzepatide doses are in the milligram range (2.5-15 mg), rather than the microgram range used for many research peptides, the reconstitution concentrations are correspondingly higher

This analysis estimates clinical eligibility and use of GLP-1 drugs among adults under age 65 in the private and employer-sponsored insurance (ESI) markets using the 2023 National Health Interview Survey (NHIS) and Merative MarketScan commercial claims data